These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34896435)

  • 1. Development of KVO treatment strategies for chronic pain in a rat model of Gulf War Illness.
    Flunker LK; Nutter TJ; Bowers CM; Cooper BY
    Toxicol Appl Pharmacol; 2022 Jan; 434():115821. PubMed ID: 34896435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of classical and non-classical voltage dependent potassium channel openers suppress nociceptor discharge and reverse chronic pain signs in a rat model of Gulf War illness.
    Cooper BY; Nutter TJ; Flunker LD; Bowers CM
    Neurotoxicology; 2022 Dec; 93():186-199. PubMed ID: 36216193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
    Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q
    J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A delayed chronic pain like condition with decreased Kv channel activity in a rat model of Gulf War Illness pain syndrome.
    Nutter TJ; Johnson RD; Cooper BY
    Neurotoxicology; 2015 Dec; 51():67-79. PubMed ID: 26409647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.
    Yeung S; Schwake M; Pucovský V; Greenwood Ia
    Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral, cellular and molecular maladaptations covary with exposure to pyridostigmine bromide in a rat model of gulf war illness pain.
    Cooper BY; Flunker LD; Johnson RD; Nutter TJ
    Toxicol Appl Pharmacol; 2018 Aug; 352():119-131. PubMed ID: 29803855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNQ2/3/5 channels in dorsal root ganglion neurons can be therapeutic targets of neuropathic pain in diabetic rats.
    Yu T; Li L; Liu H; Li H; Liu Z; Li Z
    Mol Pain; 2018; 14():1744806918793229. PubMed ID: 30027794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
    Abd-Elsayed AA; Ikeda R; Jia Z; Ling J; Zuo X; Li M; Gu JG
    Mol Pain; 2015 Jul; 11():45. PubMed ID: 26227020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
    Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD
    Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying mechanism of regulatory actions of diclofenac, a nonsteroidal anti-inflammatory agent, on neuronal potassium channels and firing: an experimental and theoretical study.
    Huang CW; Hung TY; Liao YK; Hsu MC; Wu SN
    J Physiol Pharmacol; 2013 Jun; 64(3):269-80. PubMed ID: 23959723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.
    Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K
    Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
    Mani BK; O'Dowd J; Kumar L; Brueggemann LI; Ross M; Byron KL
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):51-62. PubMed ID: 23107868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of M1 muscarinic receptors triggers transmitter release from rat sympathetic neurons through an inhibition of M-type K+ channels.
    Lechner SG; Mayer M; Boehm S
    J Physiol; 2003 Dec; 553(Pt 3):789-802. PubMed ID: 14555721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
    Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
    Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M channel enhancers and physiological M channel block.
    Linley JE; Pettinger L; Huang D; Gamper N
    J Physiol; 2012 Feb; 590(4):793-807. PubMed ID: 22155935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
    Zagorchev P; Apostolova E; Kokova V; Peychev L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of striatal cholinergic interneuron activity by the Kv7 opener retigabine and the nonsteroidal anti-inflammatory drug diclofenac.
    Paz RM; Tubert C; Stahl A; Díaz AL; Etchenique R; Murer MG; Rela L
    Neuropharmacology; 2018 Jul; 137():309-321. PubMed ID: 29758221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
    Dost R; Rostock A; Rundfeldt C
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
    Peretz A; Degani N; Nachman R; Uziyel Y; Gibor G; Shabat D; Attali B
    Mol Pharmacol; 2005 Apr; 67(4):1053-66. PubMed ID: 15598972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
    Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
    J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.